Glimiprime M 0.5mg/500mg Tablet
Manufacturer
Primus Remedies Pvt Ltd
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Key Information
Short Description
Glimiprime M 0.5mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet
Introduction
Glimiprime M 0.5mg/500mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimiprime M 0.5mg/500mg Tablet is to be taken with food.
Safety Information
Side Effects
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Alcohol Warning
It is unsafe to consume alcohol with Glimiprime M 0.5mg/500mg Tablet.
Breastfeeding Warning
Glimiprime M 0.5mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Glimiprime M 0.5mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimiprime M 0.5mg/500mg Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Glimiprime M 0.5mg/500mg Tablet may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Related Medicines
Glimigem M 0.5mg/500mg Tablet
Gride M 0.5mg/500mg Tablet
Metffil G 0.5mg/500mg Tablet
Glynamic M 0.5mg/500mg Tablet
Metwin G 0.5mg/500mg Tablet
Gemmin LS 0.5mg/500mg Tablet
Glimicure M 0.5 Tablet
Xtern GP 0.5mg/500mg Tablet
Glimcard M 0.5mg/500mg Tablet
Switglim M 0.5mg/500mg Tablet
Frequently asked questions
What are the recommended storage conditions for Glimiprime M 0.5mg/500mg Tablet?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children, and other people.
Can Glimiprime M 0.5mg/500mg Tablet lead to lactic acidosis?
Yes, Glimiprime M 0.5mg/500mg Tablet can lead to lactic acidosis. It is a medical emergency caused by an increase in lactic acid levels in the blood. It is also known as MALA (Metformin-associated lactic acidosis). This is a rare side effect associated with metformin use, and therefore it may be harmful for patients with underlying kidney disease, older adults, or those who take high amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feeling of coldness in the arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate. If you experience these symptoms, stop taking Glimiprime M 0.5mg/500mg Tablet and consult your doctor immediately.
What is Glimiprime M 0.5mg/500mg Tablet?
Glimiprime M 0.5mg/500mg Tablet is a combination of two medicines: Glimepiride and Metformin. This medication is used to treat type 2 diabetes mellitus (DM). It helps to improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas, while Metformin works by lowering glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of type 1 DM.
What are the possible side effects of Glimiprime M 0.5mg/500mg Tablet?
Glimiprime M 0.5mg/500mg Tablet is associated with common side effects, including hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. It can also lead to serious but rare side effects like lactic acidosis. Long-term use may also cause Vitamin B12 deficiency.
Can Glimiprime M 0.5mg/500mg Tablet cause Vitamin B12 deficiency?
Yes, long-term use of Glimiprime M 0.5mg/500mg Tablet can lead to vitamin B12 deficiency. It interferes with the absorption of vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems such as tingling and numbness in hands and feet, weakness, urinary problems, changes in mental status, and difficulty maintaining balance (ataxia). To avoid this, some researchers suggest taking Vitamin B12 from external sources at least once every year.
Can Glimiprime M 0.5mg/500mg Tablet cause hypoglycemia?
Yes, Glimiprime M 0.5mg/500mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to happen if you miss or delay your meals, drink alcohol, over-exercise, or take other antidiabetic medication along with it. It's essential to monitor blood sugar levels regularly, and always have a quick source of sugar like glucose tablets, honey, or fruit juice available.
Is it safe to take alcohol while taking Glimiprime M 0.5mg/500mg Tablet?
No, it is not safe to take Glimiprime M 0.5mg/500mg Tablet with alcohol, as this may lower your blood sugar levels and lead to hypoglycemia or increase the risk of lactic acidosis.
